Abstract
Overdiagnosis, or improvements in the ability to detect and diagnose small, indolent thyroid cancers, has been the primary factor contributing to the rapid increases in thyroid cancer incidence and the higher female-to-male predominance (particularly during middle adulthood) observed worldwide. However, less pronounced increases in the incidence of clinically relevant and aggressive forms of differentiated thyroid cancers have implied that there may have been a real increase in the onset and progression of thyroid cancer in the population. Whether modifiable risk factors, such as ionizing radiation exposure and obesity, could have contributed to these changing trends has been a topic of debate. Contributing to this controversy is that the etiology of differentiated thyroid cancer remains poorly understood. Epidemiologic studies are needed that can overcome the challenge of identifying “true” or causal risk factors as opposed to factors associated with a greater likelihood of incidental detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay JEM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today Lyon. France: International Agency for Research on Cancer; 2020. [Available from: https://gco.iarc.fr/today]
SEER*Explorer: An interactive website for SEER cancer statistics [Internet] [Internet]. Surveillance Research Program, National Cancer Institute. 2021 [cited November 10, 2021]. Available from: https://seer.cancer.gov/explorer/.
Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schuz J, et al. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 2021;9(3):144–52.
Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2009;20(5):525–31.
Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375(7):614–7.
Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 2020;8(6):468–70.
Panato C, Vaccarella S, Dal Maso L, Basu P, Franceschi S, Serraino D, et al. Thyroid cancer incidence in India between 2006 and 2014 and impact of overdiagnosis. J Clin Endocrinol Metab. 2020;105:8.
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.
Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225–34.
Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"—screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338–48.
Ahn HS, Kim HJ, Kim KH, Lee YS, Han SJ, Kim Y, et al. Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality. Thyroid. 2016;26(11):1535–40.
Li M, Brito JP, Vaccarella S. Long-term declines of thyroid cancer mortality: an international age-period-cohort analysis. Thyroid. 2020;30(6):838–46.
Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154(6):1420–6. discussion 6-7
NCRP. Ionizing radiation exposure of the population of the United States. Bethesda, MD; 2009.
Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Investig. 2009;39(8):699–706.
Uppal A, White MG, Nagar S, Aschebrook-Kilfoy B, Chang PJ, Angelos P, et al. Benign and malignant thyroid incidentalomas are rare in routine clinical practice: a review of 97,908 imaging studies. Cancer Epidemiol Biomark Prev. 2015;24(9):1327–31.
Park SH, Lee B, Lee S, Choi E, Choi EB, Yoo J, et al. A qualitative study of women's views on overdiagnosis and screening for thyroid cancer in Korea. BMC Cancer. 2015;15:858.
Oh CM, Lim J, Jung YS, Kim Y, Jung KW, Hong S, et al. Decreasing trends in thyroid cancer incidence in South Korea: what happened in South Korea? Cancer Med. 2021;10(12):4087–96.
Lee M, Powers AE, Morris LGT, Marti JL. Reversal in thyroid cancer incidence trends in the United States, 2000-2017. Thyroid. 2020;30(8):1226–7.
LeClair K, Bell KJL, Furuya-Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy. JAMA Intern Med. 2021;181(10):1351–8.
Lamartina L, Grani G, Durante C, Filetti S, Cooper DS. Screening for differentiated thyroid cancer in selected populations. Lancet Diabetes Endocrinol. 2020;8(1):81–8.
Mongelli MN, Giri S, Peipert BJ, Helenowski IB, Yount SE, Sturgeon C. Financial burden and quality of life among thyroid cancer survivors. Surgery. 2020;167(3):631–7.
Meernik C, Kirchhoff AC, Anderson C, Edwards TP, Deal AM, Baggett CD, et al. Material and psychological financial hardship related to employment disruption among female adolescent and young adult cancer survivors. Cancer. 2020;127(1):137–48.
Applewhite MK, James BC, Kaplan SP, Angelos P, Kaplan EL, Grogan RH, et al. Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg. 2016;40(3):551–61.
Goldfarb M, Casillas J. Thyroid cancer-specific quality of life and health-related quality of life in young adult thyroid cancer survivors. Thyroid. 2016;26(7):923–32.
Chen DW, Reyes-Gastelum D, Veenstra CM, Hamilton AS, Banerjee M, Haymart MR. Financial hardship among Hispanic women with thyroid cancer. Thyroid. 2021;31(5):752–9.
Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, et al. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 2014;120(9):1345–52.
American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
Haugen BR. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017;123(3):372–81.
Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(18):1882–7.
Ahn HS, Welch HG. South Korea's thyroid-cancer "epidemic"—turning the tide. N Engl J Med. 2015;373(24):2389–90.
Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):481–3.
Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023–9.
Kitahara CM, Sosa JA, Shiels MS. Influence of nomenclature changes on trends in papillary thyroid cancer incidence in the United States, 2000 to 2017. J Clin Endocrinol Metab. 2020;105:12.
Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomark Prev. 2009;18(3):784–91.
Pandeya N, McLeod DS, Balasubramaniam K, Baade PD, Youl PH, Bain CJ, et al. Increasing thyroid cancer incidence in Queensland, Australia 1982-2008 - true increase or overdiagnosis? Clin Endocrinol. 2016;84(2):257–64.
Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259–77.
Schonfeld SJ, Lee C, Berrington de Gonzalez A. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol). 2011;23(4):244–50.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. Hyattsville, MD; 2020.
Kitahara CM, McCullough ML, Franceschi S, Rinaldi S, Wolk A, Neta G, et al. Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid. 2016;26(2):306–18.
Rahman ST, Pandeya N, Neale RE, McLeod DSA, Bain CJ, Baade PD, et al. Obesity is associated with BRAF(V600E)-mutated thyroid cancer. Thyroid. 2020;30(10):1518–27.
Kitahara CM, Pfeiffer RM, Sosa JA, Shiels MS. Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995-2015). J Natl Cancer Inst. 2020;112(8):810–7.
Pazaitou-Panayiotou K, Polyzos SA, Mantzoros CS. Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms. Obes Rev. 2013;14(12):1006–22.
Troisi R, Bjorge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Saether SM, et al. The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med. 2018;283(5):430–45.
Rahman ST, Pandeya N, Neale RE, McLeod DSA, Baade PD, Youl PH, et al. Tobacco smoking and risk of thyroid cancer according to BRAF(V600E) mutational subtypes. Clin Endocrinol. 2021.
Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2004;89(12):6077–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kitahara, C.M. (2023). Incidence and Epidemiology of Differentiated Thyroid Cancer: Is Thyroid Cancer Incidence Truly Increasing, or Is It Simply a Finder Effect?. In: Roman, S.A., Shen, W.T., Sosa, J.A. (eds) Controversies in Thyroid Nodules and Differentiated Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-031-37135-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-37135-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-37134-9
Online ISBN: 978-3-031-37135-6
eBook Packages: MedicineMedicine (R0)